Clinical trial
Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke
NCT05643001 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 15, 2023
- Completion date
- March 28, 2025
- Enrollment
- 340 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.